[go: up one dir, main page]

TR199700020T1 - (-) - (3R) -3-methyl-4- £ 4- £ 4- (4-pyridyl) piperazin-1-yl- | phenoxy | butyric acid as cellular adhesion inhibitor. - Google Patents

(-) - (3R) -3-methyl-4- £ 4- £ 4- (4-pyridyl) piperazin-1-yl- | phenoxy | butyric acid as cellular adhesion inhibitor.

Info

Publication number
TR199700020T1
TR199700020T1 TR97/00020T TR9700020T TR199700020T1 TR 199700020 T1 TR199700020 T1 TR 199700020T1 TR 97/00020 T TR97/00020 T TR 97/00020T TR 9700020 T TR9700020 T TR 9700020T TR 199700020 T1 TR199700020 T1 TR 199700020T1
Authority
TR
Turkey
Prior art keywords
piperazin
phenoxy
pyridyl
methyl
butyric acid
Prior art date
Application number
TR97/00020T
Other languages
Turkish (tr)
Inventor
Stuart Dennett Mills
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/457,538 external-priority patent/US5652242A/en
Priority claimed from GBGB9518188.9A external-priority patent/GB9518188D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of TR199700020T1 publication Critical patent/TR199700020T1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TR97/00020T 1995-06-01 1996-05-28 (-) - (3R) -3-methyl-4- £ 4- £ 4- (4-pyridyl) piperazin-1-yl- | phenoxy | butyric acid as cellular adhesion inhibitor. TR199700020T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/457,538 US5652242A (en) 1993-03-29 1995-06-01 Heterocyclic derivatives
GBGB9518188.9A GB9518188D0 (en) 1995-09-07 1995-09-07 Optically active derivative

Publications (1)

Publication Number Publication Date
TR199700020T1 true TR199700020T1 (en) 1997-04-22

Family

ID=26307696

Family Applications (1)

Application Number Title Priority Date Filing Date
TR97/00020T TR199700020T1 (en) 1995-06-01 1996-05-28 (-) - (3R) -3-methyl-4- £ 4- £ 4- (4-pyridyl) piperazin-1-yl- | phenoxy | butyric acid as cellular adhesion inhibitor.

Country Status (31)

Country Link
EP (1) EP0796247A1 (en)
JP (1) JP2885941B2 (en)
KR (1) KR100245957B1 (en)
AT (1) AT406675B (en)
AU (1) AU710105B2 (en)
BE (1) BE1009520A5 (en)
BR (1) BR9606409A (en)
CA (1) CA2194397A1 (en)
CH (1) CH691808A5 (en)
CZ (1) CZ26997A3 (en)
DE (1) DE19680509T1 (en)
DK (1) DK10697A (en)
ES (1) ES2137886B1 (en)
FI (1) FI970393A7 (en)
GB (1) GB2304340B (en)
GR (1) GR1002702B (en)
HU (1) HUP9700274A3 (en)
IE (1) IE960405A1 (en)
IL (1) IL118477A0 (en)
IT (1) IT1290839B1 (en)
LU (1) LU90008B1 (en)
MC (1) MC2418A1 (en)
MX (1) MX9700379A (en)
NL (1) NL1003243C2 (en)
NO (1) NO307460B1 (en)
NZ (1) NZ308597A (en)
PL (1) PL318440A1 (en)
SE (1) SE510812C2 (en)
SK (1) SK13097A3 (en)
TR (1) TR199700020T1 (en)
WO (1) WO1996038416A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100158A3 (en) * 1982-07-28 1985-03-27 The Upjohn Company (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
NZ262941A (en) * 1993-03-29 1997-07-27 Zeneca Ltd Pyridine derivatives and medicaments
GB9406144D0 (en) * 1993-03-29 1994-05-18 Zeneca Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
AU710105B2 (en) 1999-09-16
MX9700379A (en) 1997-04-30
NO970437D0 (en) 1997-01-31
BE1009520A5 (en) 1997-04-01
IE960405A1 (en) 1996-12-11
FI970393L (en) 1997-01-30
PL318440A1 (en) 1997-06-09
NO970437L (en) 1997-02-20
CH691808A5 (en) 2001-10-31
DK10697A (en) 1997-04-01
AT406675B (en) 2000-07-25
CA2194397A1 (en) 1996-12-05
LU90008B1 (en) 1997-04-16
CZ26997A3 (en) 1997-08-13
EP0796247A1 (en) 1997-09-24
IT1290839B1 (en) 1998-12-14
GB2304340B (en) 1998-07-29
HUP9700274A2 (en) 1999-06-28
BR9606409A (en) 1997-09-30
NL1003243C2 (en) 1996-12-04
GB2304340A (en) 1997-03-19
JPH09512836A (en) 1997-12-22
ATA900596A (en) 1999-12-15
HUP9700274A3 (en) 2000-02-28
HU9700274D0 (en) 1997-04-28
SE510812C2 (en) 1999-06-28
ITMI961113A0 (en) 1996-05-31
ITMI961113A1 (en) 1997-12-01
ES2137886A1 (en) 1999-12-16
SE9700203L (en) 1997-01-24
FI970393A0 (en) 1997-01-30
AU5827296A (en) 1996-12-18
IL118477A0 (en) 1996-09-12
NZ308597A (en) 1998-11-25
KR100245957B1 (en) 2000-04-01
JP2885941B2 (en) 1999-04-26
GR1002702B (en) 1997-05-22
ES2137886B1 (en) 2000-08-16
MC2418A1 (en) 1997-05-23
GB9627127D0 (en) 1997-02-19
FI970393A7 (en) 1997-01-30
SE9700203D0 (en) 1997-01-24
DE19680509T1 (en) 1997-12-04
NO307460B1 (en) 2000-04-10
WO1996038416A1 (en) 1996-12-05
SK13097A3 (en) 1997-08-06
KR970704689A (en) 1997-09-06

Similar Documents

Publication Publication Date Title
MX9705005A (en) MICROSOMIC TRIGLYCERIDE TRANSFER PROTEIN INHIBITORS AND METHOD.
DE19680255T1 (en) Rotamase enzyme activity inhibitors
FI965019A7 (en) Enzyme inhibitors
NO974213L (en) Small molecular inhibitors of rotamase enzyme activity
TR199501472A2 (en) Matrix metalloprotease inhibitors.
NO20006718D0 (en) protease inhibitors
DE69522690D1 (en) alpha-ketogultaric acid dehydrogenase gene
DK0925303T3 (en) Phosphinic acid amides as matrix metalloprotease inhibitors
NO993587D0 (en) Sulfonamide metalloprotease inhibitors
FR2769318B1 (en) HYDROPHOBIC COATING, ESPECIALLY FOR GLAZING
TR199501451A2 (en) £ 2- (2-alkoxy-6-trifluormetilpirimi-4-yl) oxymethyl AN) | -phenyl-acetic acid derivatives, methods and intermediates for their production and their use.
EE9900180A (en) Substituted 4-Biphenyl-4-hydroxybutanoic Acid Derivatives as Metalloprotease Matrix Inhibitors
NO911459D0 (en) USE OF METALLION COMPLEXS AS INVESTMENT INHIBITORS.
BR9610075A (en) Prolyl endopeptidase inhibitors
TR199700020T1 (en) (-) - (3R) -3-methyl-4- £ 4- £ 4- (4-pyridyl) piperazin-1-yl- | phenoxy | butyric acid as cellular adhesion inhibitor.
TR199600607A2 (en) Para-hydroxyphenylacetic acid for reducing the repellency of insecticides.
IT239603Y1 (en) SHOE STRUCTURE, PARTICULARLY FOR SKATES
NO965353D0 (en) 3-Amino-2-oxo-1-piperidinedacetic acid derivatives as enzyme inhibitors
ID22205A (en) HOLIDAY SHOES PIT
ITRM960100V0 (en) ANTIQUE EFFECT FILM CRAQUELURES FOR CONTACT.
GB9610093D0 (en) (-)-(3R)-methyl-4-[4-[4-(4-pyridyl) piperazin-1-yl] phenoxy] butyric acid
KR970000223A (en) Cholesterol biosynthesis inhibitors
ZA964509B (en) (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy}butyric acid
IT1275260B (en) NAIL PARTICULARLY FOR FOOTWEAR
ITBO970676A0 (en) BENDING METHOD, PARTICULARLY OF TABLETS.